Global In-Vitro Toxicology Testing Market Trends and Future Outlook to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The In-Vitro Toxicology Testing Market?
In recent times, there has been swift expansion in the scope of the in-vitro toxicology testing market. The market, which stood at $11.53 billion in 2024, is projected to surge to $12.73 billion by 2025, growing at a compound annual growth rate (CAGR) of 10.4%. This robust growth during the historic period has been largely driven by factors such as regulatory mandates, ethical considerations and animal rights, efficiency in terms of cost and time, proliferation of the global pharmaceutical industry, pressures related to drug discovery and development, along with heightened public awareness about environmental toxins.
Expectations are high for the in-vitro toxicology testing market to experience substantial growth in the coming years, with projections putting its worth at $19.02 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.6%. Factors contributing to its expansion during this forecasted period include a growing interest in personalized medicine, an increasing need for predictive toxicology models, more extensive environmental testing, challenges in the development of oncology drugs, a focus on endocrine disruptor screening, and a shift towards multi-organ chips. Looking forward, trends to monitor within this period encompass advancements in 3d cell culture technologies, integration of high-throughput screening procedures, focus on organ-on-a-chip technologies, application in chemical safety assessment, usage of human-derived cell lines, the incorporation of omics technologies, as well as educational initiatives and training programs.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp
What Are The Primary Factors Supporting The In-Vitro Toxicology Testing Market Expansion?
The in-vitro toxicology testing market is projected to be boosted due to the increasing healthcare expenses. The total money that is funneled into healthcare facilities such as hospitals, home health services, prescription pharmaceuticals, nursing amenities, and individual healthcare by people and the government is the health expenditure. This is increasing around the globe due to the climbing disease prevalence that necessitates in-vitro toxicology testing. As an example, from 2023 to 2032, the Centers for Medicare & Medicaid Services, a federal agency in the US, forecasted in their September 2024 report that the average growth rate of national health expenditure (NHE) is anticipated to be 5.6%, outstripping the average GDP growth rate of 4.3%. Therefore, the health spending portion of GDP is predicted to escalate from 17.3% in 2022 to 19.7% in 2032. Hence, the burgeoning healthcare expenditure is propelling the in-vitro toxicology testing market forward.
Which Segments Define The Structure Of The In-Vitro Toxicology Testing Market?
The in-vitro toxicology testingmarket covered in this report is segmented –
1) By Product And Service: Consumables; Assays; Equipment; Software; Services
2) By Method: Cellular Assays; Biochemical Assays; In Silico Models; Ex Vivo Models
3) By Technology: Cell Culture Technologies; High-throughput Technologies; Toxicogenomics
4) By Applications: Neurotoxicity; Dermal toxicity; Cytotoxicity; Other Applications
5) By Industry: Pharmaceuticals And Biopharmaceuticals; Cosmetic And Household Products; Food; Chemicals
Subsegments:
1) By Consumables: Reagents; Cell Culture Media; Plates And Vials
2) By Assays: Cell-Based Assays; Biochemical Assays; Genetic Toxicity Assays
3) By Equipment: Automated Systems; Microscopes; Plate Readers
4) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Toxicology Modeling Software
5) By Services: Testing Services; Consultation Services; Regulatory Compliance Services
Which Disruptive Trends Are Driving Change Across The In-Vitro Toxicology Testing Market?
The emergence of creative cell treatments is a prevalent trend catching attention in the in-vitro toxicology industry. Big businesses in the in-vitro toxicology assessment market are concentrating on creating innovative financing solutions to fortify their presence. For illustration, Waypoint Bio, a Biotechnology company based in the US has proclaimed in June 2024, the procurement of $14.5 million as seed funding to further explore cell therapies for solid tumors utilizing in vivo spatial pooled screening technology. This unique platform amalgamates spatial biology with pooled screening, thereby facilitating the simultaneous study of the complex interplay of different cell therapy aspirants with the solid tumor microenvironment. It assesses numerous phenotypes at a micro, single-cell level, aiding researchers in discerning not only the therapies that work, but also the reasons behind their success or failure, a factor heavily reliant on their interaction within the tumor milieu.
Who Are The Primary Market Leaders In The In-Vitro Toxicology Testing Market?
Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
What Regional Factors Are Accelerating Growth In The In-Vitro Toxicology Testing Market?
North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7987&type=smp
Browse Through More Reports Similar to the Global In-Vitro Toxicology Testing Market 2025, By The Business Research Company
Veterinary Laboratory Testing Services Global Market Report 2025
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
Veterinary Reference Laboratory Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
